Price
Target price
€0.25
€0.25
-0.200%
-0.0005
-0.200%
-
09.05.24 / Stuttgart Stock Exchange
WKN: A3DTK2 / Name: InMed Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
InMed Pharmaceuticals Inc. Stock
InMed Pharmaceuticals Inc. shows a slight decrease today, losing -€0.001 (-0.200%) compared to yesterday.
Our community identified positive and negative aspects for InMed Pharmaceuticals Inc. stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the InMed Pharmaceuticals Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of InMed Pharmaceuticals Inc. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of InMed Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc. | -0.200% | 5.567% | -22.240% | -77.344% | -28.343% | -99.606% | -99.901% |
| Promis Neurosciences Inc. | 4.880% | 0.000% | -20.370% | -69.286% | 72.864% | -74.519% | -83.037% |
| Resverlogix Corp | - | 0.000% | 0.000% | -60.963% | -15.116% | -93.917% | -98.784% |
| Enwave Corporation | -4.240% | -10.000% | -21.134% | -42.481% | -37.805% | -83.827% | -89.961% |
